Ratings by Morgan Stanley (Judah C. Frommer)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/14/2026 | Zenas Biopharma | ZBIO | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/14/2026 | Compass Pathways | CMPS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/28/2026 | Incyte | INCY | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/24/2026 | Compass Pathways | CMPS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/24/2026 | Compass Pathways | CMPS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/16/2026 | Zenas Biopharma | ZBIO | Maintain | Equalweight (N/A) |
|
Details |
